Globus Medical (GMED) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally.

Total Revenue Chart for Globus Medical

Globus Medical (GMED) revenue for FY2025 was USD 2.9B, a 16.7% change from FY2024. Globus Medical's revenue grew from USD 254.3M in 2009 to USD 2.9B in 2025 (1055.5% over 16 years). Earnings per share grew from USD 0.72 in 2010 to USD 1.85 in 2022 (156.7%). Revenue compound annual growth rate: 5-year CAGR of 30.1%, 10-year CAGR of 18.4%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$10.26B
Implied Share Price
$91.76
Enterprise Value
$9.45B
Revenue (TTM)
$3.14B
EBITDA
$1.01B
Profit Margin
17.03%
Trailing P/E
19.60
Forward P/E
13.87
Price/Book (MRQ)
2.08
Price/Sales (TTM)
3.26
EV/EBITDA
9.90
EV/Revenue
3.00
Dividend Yield
—
Book Value
$35.52
Free Cash Flow (FY2025)
$588.77M
Free Cash Flow Yield
5.74%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.